Ovarian Cysts Market Research Report – Forecast till 2027

Ovarian Cysts Market Research Report: By Type (Functional Cysts, Non-Functional Cysts) By Diagnosis (Imaging, CA-125 Blood Test, Laparoscopy) By Treatment (PCOS Drugs, Surgery) By End Users (Hospitals, Research Organization) - Forecast till 2027al

ID: MRFR/Pharma/1252-HCR | February 2021 | Region: Global | 90 pages

Ovarian Cysts Market Scenario: 


Ovarian cysts are closed, sac-like structures filled with a liquid or semisolid substance within the ovary. Ovarian cysts are quite common in women who ovulate and the chances for the development of such cysts after menopause are less. However, the formation of ovarian cysts even after menopause is reported. This condition is marked by high risks for ovarian cancer. Most of the ovarian cysts are discovered during a routine pelvic exam. According to a study published in the Journal of Clinical Research in Paediatric Endocrinology in 2017, the frequency of ovarian cysts is about 1.8% in children aged between 5-9 years and 18.8% in those who aged between 10-18 years. Moreover, it is estimated that with the onset of adolescence and increasing age, the frequency of ovarian cysts increases and ranges between 3.8%-31.3%. Such trends in the prevalence of the ovarian cysts are one of the major drivers of the market growth. Moreover, rising healthcare expenditures and increasing awareness about woman health boost the market growth. However, lack of awareness and low per capita healthcare expenditure in the developing countries may restrain the market growth. 


The ovarian cysts market is expected to grow at an approximate CAGR of 8.2% during the forecast period. 


Figure 1:- Ovarian Cysts Global Market share, by region Ovarian Cysts Market


Sources: WHO, annual reports, press release, white paper, and company presentation


 Ovarian Cysts Market Segmentation


The global ovarian cysts market is segmented on the basis of type, diagnosis, treatment, and end users.


On the basis of the type, the ovarian cysts market is segmented into functional cysts, non-functional cysts, and others. The functional cysts segment by type is sub-segmented into the follicular cyst, corpus luteum cyst, and others. The non-functional cysts segment by type is sub-segmented into dermoid cysts, cystadenomas, endometriomas, and others.


On the basis of the diagnosis, the ovarian cysts market is segmented into imaging, CA-125 blood test, laparoscopy, and others. The imaging segment is sub-segmented into CT scan, MRI, ultrasound, and others.


On the basis of the treatment, the ovarian cysts market is segmented into medication, polycystic ovary syndrome (PCOS) drugs, pain relievers, surgery, and others. The pain relievers are sub-segmented into acetaminophen, non-steroidal anti-inflammatory drugs, opioids, and others.


On the basis of the end users, the ovarian cysts market is segmented into hospitals & clinics, medical institutes, research organization, and others.


 Ovarian Cysts Market Regional Analysis


America dominates the global ovarian cysts market owing to a well-developed healthcare sector and huge patient population for ovarian cysts. Apart from this, changing lifestyle and increasing healthcare expenditure have boosted the growth of the ovarian cysts market in America. In 2015, according to the Centres for Disease Control and Prevention, in the U.S. the total healthcare expenditure accounted for 17.8% of the total gross domestic product (GDP), which accounted for USD 3.2 trillion. 


Europe is the second largest ovarian cysts market, which is followed by Asia Pacific. Availability of funds for research, huge patient population, increasing healthcare expenditures, well-developed healthcare sector and government support for research & development are projected to drive the ovarian cysts market growth during the forecasted period. Regionally, Europe is divided into Western Europe and Eastern Europe. Western Europe holds the major share of the regional market, which is majorly contributed by Germany, the U.K., and France. However, Eastern Europe is the fastest growing region due to the huge opportunities in the untapped market. 


Asia Pacific is the fastest growing region in the global ovarian cysts market due to the presence of a huge patient population, continuously developing economies like India and China, and presence of huge opportunity in the market. Moreover, favorable government policies and increasing healthcare expenditures fuel the market growth within the region. 


On the other hand, the Middle East & Africa holds the least share of the global ovarian cysts market due to the presence of poor economy, especially, in the African region. Majority of the market of this region is held by the Middle East due to the well-developed healthcare sector and huge healthcare expenditure by the presence of economies like Kuwait, Saudi Arabia, Dubai, and Qatar.  


Ovarian Cysts Market- Key Players 


Pfizer Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (The Middle East & Africa), Quest Diagnostics Incorporated. (U.S.), Novartis AG (Europe), General Electric Company (Europe), Merck & Co., Inc. (U.S.), Boston Scientific Corporation (U.S.), and Medtronic (U.S)


 Research Methodology 


Global Ovarian Cysts Market


Sources: WHO, annual reports, press release, white paper, and company presentation 


Intended Audience



  • Pharmaceutical companies

  • Biotechnological institutes

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Market Research and Consulting Service Providers 



Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :


ovarian cysts market is expected to expand at 8.2% CAGR from 2017 to 2023.

ovarian cysts market is driven by the high prevalence of cysts among women.

Lack of awareness among women and low healthcare expenditure of nations are challenges faced by the global ovarian cysts market.

The Americas can dominate the global ovarian cysts market by 2023.

Novartis AG, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Medtronic, Pfizer Inc., Quest Diagnostics Incorporated, General Electric Company, and Boston Scientific Corporation are major players currently working in the global ovarian cysts market.

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Ovarian Cysts Market, by Type

6.1 Introduction

6.2 Functional Cysts

Market Estimates & Forecast, 2020-2027

6.2.1 Follicular cyst

6.2.2 Corpus luteum cyst

6.2.3 Others

6.3 Non-Functional Cysts

Market Estimates & Forecast, 2020-2027

6.3.1 Dermoid cysts

6.3.2 Cystadenomas

6.3.3 Endometriomas

6.3.4 Others

6.4 Others

Chapter 7. Global Ovarian Cysts Market, by Diagnosis

7.1 Introduction

7.2 Imaging

Market Estimates & Forecast, 2020-2027

7.2.1 CT scan

7.2.2 MRI

7.2.3 Ultrasound

7.2.4 Others

7.3 CA-125 Blood Test

Market Estimates & Forecast, 2020-2027

7.4 Laparoscopy

Market Estimates & Forecast, 2020-2027

7.5 Others

Chapter 8. Global Ovarian Cysts Market, by Treatment

8.1 Introduction

8.2 Medication

Market Estimates & Forecast, 2020-2027

8.3 Polycystic Ovary Syndrome (PCOS) Drugs

Market Estimates & Forecast, 2020-2027

8.4 Pain Relievers

Market Estimates & Forecast, 2020-2027

8.4.1 Acetaminophen

8.4.2 Non-steroidal Anti-Inflammatory Drugs

8.4.3 Opioids

8.4.4 Others

8.5 Surgery

8.6 Others

Chapter 9. Global Ovarian Cysts Market, by End Users

9.1 Introduction

9.2 Hospitals & Clinics

Market Estimates & Forecast, 2020-2027

9.3 Medical Institutes

Market Estimates & Forecast, 2020-2027

9.4 Research Organization

Market Estimates & Forecast, 2020-2027

9.5 Others

Chapter 10. Global Ovarian Cysts Market, by Region

10.1 Introduction

10.2 America

10.2.1 North America

10.2.1.1 US

10.2.1.1 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

Chapter 12 Company Profiles

12.1 Pfizer Inc.

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.2.4 Key Developments

12.1.5 SWOT Analysis

12.2 Teva Pharmaceutical Industries Ltd.

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Quest Diagnostics Incorporated.

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Novartis AG

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 General Electric Company

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Merck & Co., Inc.

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Boston Scientific Corporation

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Medtronic

12.8.1 Overview

12.8.2 Product Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Others

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Ovarian Cysts Market

Chapter 14 Appendix

LIST OF TABLES

Table 1 Ovarian Cysts Industry Synopsis, 2020-2027

Table 2 Global Ovarian Cysts Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Global Ovarian Cysts Market by Region, 2020-2027, (USD Million)

Table 4 Global Ovarian Cysts Market by Type, 2020-2027, (USD Million)

Table 5 Global Ovarian Cysts Market by Diagnosis, 2020-2027, (USD Million)

Table 6 Global Ovarian Cysts Market by Treatment, 2020-2027, (USD Million)

Table 7 Global Ovarian Cysts Market by End Users, 2020-2027, (USD Million)

Table 8 North America Ovarian Cysts Market by Type, 2020-2027, (USD Million)

Table 9 North America Ovarian Cysts Market by Diagnosis, 2020-2027, (USD Million)

Table 10 North America Ovarian Cysts Market by Treatment, 2020-2027, (USD Million)

Table 11 North America Ovarian Cysts Market by End Users, 2020-2027, (USD Million)

Table 12 U.S. Ovarian Cysts Market by Type, 2020-2027, (USD Million)

Table 13 U.S. Ovarian Cysts Market by Diagnosis, 2020-2027, (USD Million)

Table 14 U.S. Ovarian Cysts Market by Treatment, 2020-2027, (USD Million)

Table 15 U.S. Ovarian Cysts Market by End Users, 2020-2027, (USD Million)

Table 16 Canada Ovarian Cysts Market by Type, 2020-2027, (USD Million)

Table 17 Canada Ovarian Cysts Market by Diagnosis, 2020-2027, (USD Million)

Table 18 Canada Ovarian Cysts Market by Treatment, 2020-2027, (USD Million)

Table 19 Canada Ovarian Cysts Market by End Users, 2020-2027, (USD Million)

Table 20 South America Ovarian Cysts Market by Type, 2020-2027, (USD Million)

Table 21 South America Ovarian Cysts Market by Diagnosis, 2020-2027, (USD Million)

Table 22 South America Ovarian Cysts Market by Treatment, 2020-2027, (USD Million)

Table 23 South America Ovarian Cysts Market by End Users, 2020-2027, (USD Million)

Table 24 Europe Ovarian Cysts Market by Type, 2020-2027, (USD Million)

Table 25 Europe Ovarian Cysts Market by Diagnosis, 2020-2027, (USD Million)

Table 26 Europe Ovarian Cysts Market by Treatment, 2020-2027, (USD Million)

Table 27 Europe Ovarian Cysts Market by End Users, 2020-2027, (USD Million)

Table 28 Western Europe Ovarian Cysts Market by Type, 2020-2027, (USD Million)

Table 29 Western Europe Ovarian Cysts Market by Diagnosis, 2020-2027, (USD Million)

Table 30 Western Europe Ovarian Cysts Market by Treatment, 2020-2027, (USD Million)

Table 31 Western Europe Ovarian Cysts Market by End Users, 2020-2027, (USD Million)

Table 32 Eastern Europe Ovarian Cysts Market by Type, 2020-2027, (USD Million)

Table 33 Eastern Europe Ovarian Cysts Market by Diagnosis, 2020-2027, (USD Million)

Table 34 Eastern Europe Ovarian Cysts Market by Treatment, 2020-2027, (USD Million)

Table 35 Eastern Europe Ovarian Cysts Market by End Users, 2020-2027, (USD Million)

Table 36 Asia Pacific Ovarian Cysts Market by Type, 2020-2027, (USD Million)

Table 37 Asia Pacific Ovarian Cysts Market by Diagnosis, 2020-2027, (USD Million)

Table 38 Asia Pacific Ovarian Cysts Market by Treatment, 2020-2027, (USD Million)

Table 39 Asia Pacific Ovarian Cysts Market by End Users, 2020-2027, (USD Million)

Table 40 Middle East & Africa Ovarian Cysts Market by Type, 2020-2027, (USD Million)

Table 41 Middle East & Africa Ovarian Cysts Market by Diagnosis, 2020-2027, (USD Million)

Table 42 Middle East & Africa Ovarian Cysts Market by Treatment, 2020-2027, (USD Million)

Table 43 Middle East & Africa Ovarian Cysts Market by End Users, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Ovarian Cysts Market

Figure 3 Market Dynamics for Global Ovarian Cysts Market

Figure 4 Global Ovarian Cysts Market Share, by Type 2020

Figure 5 Global Ovarian Cysts Market Share, by Diagnosis 2020

Figure 6 Global Ovarian Cysts Market Share, by Treatment, 2020

Figure 7 Global Ovarian Cysts Market Share, by End Users, 2020

Figure 8 Global Ovarian Cysts Market Share, by Region, 2020

Figure 9 North America Ovarian Cysts Market Share, by Country, 2020

Figure 10 Europe Ovarian Cysts Market Share, by Country, 2020

Figure 11 Asia Pacific Ovarian Cysts Market Share, by Country, 2020

Figure 12 Middle East & Africa Ovarian Cysts Market Share, by Country, 2020

Figure 13 Global Ovarian Cysts Market: Company Share Analysis, 2020 (%)

Figure 14 Pfizer Inc.: Key Financials

Figure 15 Pfizer Inc.: Segmental Revenue

Figure 16 Pfizer Inc.: Geographical Revenue

Figure 17 Teva Pharmaceutical Industries Ltd.: Type UK Ltd: Key Financials

Figure 18 Teva Pharmaceutical Industries Ltd.: Type UK Ltd: Segmental Revenue

Figure 19 Teva Pharmaceutical Industries Ltd.: Type UK Ltd: Geographical Revenue

Figure 20 Quest Diagnostics Incorporated. : Key Financials

Figure 21 Quest Diagnostics Incorporated.: Segmental Revenue

Figure 22 Quest Diagnostics Incorporated.: Geographical Revenue

Figure 23 Novartis AG: Key Financials

Figure 24 Novartis AG: Segmental Revenue

Figure 25 Novartis AG: Geographical Revenue

Figure 26 General Electric Company: Key Financials

Figure 27 General Electric Company: Segmental Revenue

Figure 28 General Electric Company: Geographical Revenue

Figure 29 Merck & Co., Inc.: Key Financials

Figure 30 Merck & Co., Inc.: Segmental Revenue

Figure 31 Merck & Co., Inc.: Geographical Revenue

Figure 32 Boston Scientific Corporation: Key Financials

Figure 33 Boston Scientific Corporation: Segmental Revenue

Figure 34 Boston Scientific Corporation: Geographical Revenue

Figure 35 Medtronic: Key Financials

Figure 36 Medtronic: Segmental Revenue

Figure 37 Medtronic: Geographical Revenue